Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dr Bala, our end of August submission timeline check is coming up quickly.
How did the specials revenue do last quarter? You called that non sensical!
How cool is it that Fireman posted that he made the same profit on AVXL board? Nice coincidence!
I forget you are both smart and lucky!
Hey, it can be a coincidence! They are both smart and lucky! ;)
Excellent. Hopefully, you don’t get tricked by your friends again, where you are forced to average down every few months.
It seemed like they tricked you into believing that a UK approval could come through in Q2 - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171087466
“Any info how one would go about becoming a firefighter in NY?”
Check in with your earlier virtual avatar, if that exists, LOL! Alternatively, reach out to him on Twitter. You both own pretty the same number of shares. ;)
You have been saying the same thing for over 2 years that another 6-9 months here and there does not matter. Of course under your Fireman alias earlier. It’s very likely we will hear the same thing again in Q1 2024 that another 6-9 months is no big deal, and so the saga continues!
Your friend at the bar tricked you into investing way too much too soon last year, isn’t it? ;)
Never said I am advising anyone at CLPT. You can go back and check all my messages. What I have said is that some of the executive team members including their CEO and I have been colleagues at a former company. And I stand by that.
What about Evis Husever at EW Healthcare. Is that still in play? Or your new pump narrative is Cancer Moonshot? ;)
Funny how the conversations haven’t changed much today (7 years from that point on). Feel for all the folks that got wiped out during that time.
Good reminder as to what this management is capable of!
Nope, you are just a pumper and trader! What happened to your shareprice going to the moon forecast for Dec 2022? I have to give it to you that you got a lot of retail to buy your shares over a dollar last fall with that prediction. So you did have last laugh then. Perhaps you are preparing for another rinse and repeat with cancer moonshot narrative now?
Is Evis Hursever from EW Healthcare still in play, LOL?
Excellent. Please also have your friends accumulate a lot more so we can stop the bleeding!
Otherwise the opportunity in a lifetime will keep on giving the rest of the year and will get better with every passing week/month!
Nothing to do with NWBO. Given the governance issue with this company over the last 15 years, a big pharma will see a lot of risk and likely distance themselves.
The important thing to watch out for is there will be no application submission or acceptance this year and share price will continue to slide. You can blame it on MMs or spoofers but I blame it on the management.
Yup, bad governance and history over the last 15 years will cause anyone to stop. Old habits die hard and any credible institution will see too much risk to engage further with this group.
The only financing they will get is from the likes of Thermo who work closely with the management to eventually dump these shares to retail. Rinse and repeat.
The opportunity will be even better in early 2024. At this rate, we might get back to .20 cents near the end of the year. Have a lot of dry powder to average down then!
He is a well known pumper! Do the opposite of what he says and you will do well with your money.
He is close with LG so the lying behavior rubs off!
“Investing in a unicorn company is not about timing. It is about being invested.”
— nope, this doesn’t work in case of NWBO. If so, the folks that bought in $5-10 range 8-9 years ago should have been well rewarded by now. Instead they got diluted like hell! They might never break even. In contrast, many companies gained 10,000% during that stretch!
LOL, it was a 3-day event where multiple talks and posters were presented including by their own teams and other pharmas. While it’s positive that they attended the talk, it’s not uncommon for the same set of folks to show up in many other talks at the meeting.
Even if the presentation piqued their interest, it’s more likely that they may have distanced themselves as they started talking with LP, LG, and others and seen how pervasive the bad governance has been within the group over the years. Too much risk!
Love your optimism, but I don’t think big pharma takes NWBO seriously with this management at the helm. You can sense some frustration with Bigger too as he spoke about potentially taking up an activist role at MAA submission.
The 15 year history does not favor this management as they have repeatedly diluted the shareholders to oblivion.
LOL, only happens in NWBO world. I still have a hard time believing that big pharma is actually talking to them or taking them seriously. Just imagine if they say this to big pharma folks that we have prepared 1.7 million pages and 27 modules but we are thinking of adding more pages and working on Flaskworks certification before we apply to regulatory agencies. It took us 3 years from data lock to get to this point and share price is only under .45 cents, so adding another few months is not a big deal.
However, we need your cash injection now to run a combo trial!
“Will I get my Wells letter before or after that? Before or after the NEXT Swiss approval?”
— LOL, I don’t know. Ask the person that brought this up. Maybe you are not employed by Virtu because they seem to have gotten one.
“I'll just keep you on ignore instead of arguing with a fool, which is pointless.”
— One of the best decisions you will make here! ;)
BS. You apply for a single indication in one jurisdiction as quickly as you can when you are struggling to keep the lights on. You don’t waste time and continue to finance at depressed valuation when you have had an opportunity to submit UK application for GBM soon after MIA in April. They are hiding some things and it will become obvious to folks when we approach the end of the year with no news.
They can speak about 1.7 million pages and 27 modules but not about what that actually means in terms of where exactly they are applying, when, and what indication? No one buys the crap anymore.
You are again back to one of these excuses I laid out a few months ago.
1) The focus has shifted to FDA now? UK not number one priority anymore. So need more time to line up CRL and other million BLA pages?
2) Now applying strategically via Project Orbis. All RAs at once. Need extra months.
3) Flaskworks certification given off label demand considerations!
4) Tissue agnostic approvals.
5) No MAA acceptance PR. Need to wait until final MHRA approval (in 2024?) for the big reveal.
6) Rolling review already in the works. Approvals can come anytime.
Sounds like excuse number 3 and 4 is what you are going for! Will you be disappointed if only a UK application for GBM indication is submitted in the end?
Better suited for Ex, LC and IC! I’d be more than happy if these MMs get exposed and some of them go bankrupt as soon as possible. But I am also a realist and know that it’s not going to be easy. Ultimately one or two may fall if everything goes according to plan but it might take a few years.
However, it would also be a relief if this management is booted out! A bunch of liars and inept individuals that continue to screw retail investors.
Here’s one of his post from September 2022. There are many such (incoherent) articles from him in the last year or so.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169867409
We missed that trip to the moon last Christmas. Perhaps it will happen in December 2024?
“I still have some friends/family that ping me daily trying to get out. My advice remains this: you’re in deep already! Pray for a miracle pump then get out.”
— Good advice. Old habits (of this management) die hard and they will continue to find ways to screw retail. Folks that bought between $1 and $2 last year or beginning of this year are stuck, unfortunately. I can’t imagine what it must be like for folks that bought in the $4-5 range 7-8 years ago.
Although, I doubt we see a spike anytime soon. And when it does happen, it will be too little too late because the share price would be so depressed by then that even a double or triple on a surprise positive news cycle will keep the share price lid at under .70 to .80 cents at the max.
Furthermore, it wouldn’t be surprising if it turns out that management was BSing about the partnership discussion or it goes nowhere. It’s another carrot they are trying to dangle like the $3M prepayment from the previous quarter, but no one is falling for it anymore. Ultimately, as with all things it will be forgotten in a couple of quarters and the narrative will shift to something else. However, the one thing that will remain consistent is the share price in penny land!
You have been all over the place over the last 12-15 months. From Evis Hursever and EW Healthcare partnership to some other 4th female phenom to going to the moon valuation taking place before last Christmas to Merck to Regeneron to who knows what you will come up with next.
The reality is as long as you, Hoffy, DD, etc continue to pump non stop and/or defend management on a daily basis, nothing is coming anytime soon.
I agree with you. MAA submission is baked in given how long this has taken. Even approval in the UK without significant reimbursement news will not move the needle much. The shorts will continue to ask question around the extent of reimbursement coverage, manufacturing, logistical challenges, profitability, and so on. They will use the opportunity to slam it down at every opportunity in the rare instance there is a brief spike to $1 or thereabouts, and we will be back to penny land in no time.
Revenue is not going to scale up in a meaningful fashion with this team for at least couple of years, if not more. There is no hiring on the NWBO side either.
Only a big pharma partnership(s) with significant cash injection (>$250M) to run a combo trial will change the situation. Outside this, they remain a boutique shop.
It’s coming whether you like it or not. Big dilution at under .40 cents. And if they sell the rest of C shares at .45 cents, it will be hailed as a big victory by social media army!
LOL. There is a pattern. He creates anticipation so he can continue to dump his shares to retail. JAMA comment last summer and then UK submission comment this spring.
He will come again in October and say he is still around and that everything takes longer with NWBO. He will apologize that UK application hasn’t been submitted and will feel sorry that our share price is still under .40 cents.
It was obvious low .40 or high .30 was coming this autumn/fall with no news. But it’s happening a lot sooner. It’s possible we might get to low .30s or high .20s this fall given the pace of decline and no news!
But the pumpers will say you will have an opportunity of a lifetime to buy at the bargain basement price. Have some dry powder later this year! ;)
I agree. Both LG and DI are pathological liars! He has been stuck on the 1 yard for almost 3 years now. And they are working very very very hard.
They can’t even control what’s in their hands and that’s to submit the application. They have had 3 years to prepare for this. In contrast, most companies big or small do it in less than a year.
You are arguing with the wrong person on the data and the KOLs supporting this technology. I am on the same side.
But not when it comes to this management.
So many but you know it already. LG’s UK approval imminent comment in summer 2020 is in the running for the top award when he already knew PIP and manufacturing approvals were not even close!
LP is not far behind though!
And thanks for connecting all the funds that go out by NIH divisions to FDA approval! Can’t wait for our BLA submission.
Slight correction. No faith in the unethical and dishonest management team (except MB and Boyton perhaps if he is still active). Hopefully, someone boots this management sooner than later. Where else would you see a lying 77 year old being persisted with as a full time executive for business development?
I come from this world and quite familiar with it. NIH and it’s divisions fund billions of dollars for research. They fund a lot of grants (hundreds of millions of dollars) for basic research, training, and so on.
However, majority of the funding does not turn into ph 1/2 trial or even a research product for that matter. Forget about clinical!
But I know your job is to link anything positive you can find to NWBO because the whole universe revolves around it (except the share price).
He doesn’t understand that NCI has no connection to FDA. They fund millions of dollars every year for cancer research and bulk of it does not result in an approved product. Some does not even get to ph 1/2 studies but that doesn’t deter these guys from their mission of pumping and defending the management every single day. Pumping part is at least not working, but they have been successful in shielding the management and getting them way more shares than they deserve while retail is being jerked around.
He is a liar! You have to take everything that LG says with a grain of salt.
We are just as close now as we were when you had that meeting with your friend in the bar last December. Share price cut by over 60-70% from that point on.
“It would be my hope that LP's invited to the JP Morgan Healthcare Conference in early January. I know that conference is considered one of the most prestigious to be invited to.”
- not that difficult to get invited to if you are moderately well connected. I see Novocure there. As with everything NWBO, they simply don’t have the right attitude and energy to go after these initiatives. What do you expect from a team of semi retired executive folks? I am not aware of any biotech company that has a 77 year old full time executive serving as the Vice President of Business Development.
“The daily fluctuation is meaningless for the long-term investors.”
- now you’re making fun of the long term investors that bought about 8-10 years ago around 5 dollar range?